The 2026 State of Nursing Survey finds only 22% of nurses trust AI tools for patient care and 60% say they were never adequately trained on the technology, though trust nearly doubles among nurses who had a say in selecting the tools.
Leica Biosystems received FDA clearance for Aperio iQC DX, the first standalone AI quality-control tool for clinical digital pathology, which caught up to 24% more slide artifacts than histotechnicians in a Heidelberg University study.
Pfizer signed a license agreement with AI biologics startup Chai Discovery on June 4, 2026, gaining access to Chai-3, a model the company says doubled the success rate of therapeutic antibody design over its predecessor.
Clair Health raised $11.6 million led by Khosla Ventures to build a wrist wearable that uses machine learning to infer estrogen, progesterone, LH and FSH levels without blood tests, launching in November.
A Nature Medicine study found OpenAI's ChatGPT Health under-triaged more than half of emergency-care cases and showed inverted suicide-risk alerts, testing the tool across 960 clinical interactions.
Labcorp will deploy PathAI's FDA-cleared AISight Dx digital pathology platform across its national lab network, extending a partnership that began with a 2019 strategic investment.
Merck and Google Cloud announced a multi-year, up-to-$1-billion partnership embedding Google engineers directly inside Merck's operations to deploy agentic AI across R&D, manufacturing and commercial functions.
NVIDIA and Eli Lilly unveiled a five-year, $1 billion co-innovation AI lab in the San Francisco Bay Area, built on NVIDIA's BioNeMo platform, aiming to accelerate drug discovery, clinical development, and manufacturing.
Aidoc's CARE foundation model won FDA clearance to flag 14 acute conditions from a single abdominal CT scan, a consolidation the company says cuts false alerts roughly tenfold versus running separate single-purpose AI tools.
The NHS-linked GEMINI study found AI-assisted mammography screening increased breast cancer detection by 10.4% while cutting radiologist reading time by up to a third, intensifying pressure on other countries' screening programs.